BARCLAYS PLC: CBZ position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BARCLAYS PLC on CBZ, newest first. How the timeline and the estimate are built.
BARCLAYS PLC held 114,157 CBZ shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 114,157 sharesChange vs previous 13F +69,774 shares
<0.01% of the 13F portfolio, value $3,662,156.
13F-HR 0000312069-26-000223 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 44,383 sharesChange vs previous 13F -45,714 shares
<0.01% of the 13F portfolio, value $1,191,683.
13F-HR 0000312069-26-000139 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F/A 90,097 sharesChange vs previous 13F +28,585 shares
<0.01% of the 13F portfolio, value $4,771,538.
13F-HR/A 0000312069-26-000090 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F/A 61,512 sharesChange vs previous 13F -24,098 shares
<0.01% of the 13F portfolio, value $4,666,300.
13F-HR/A 0000312069-26-000079 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F/A 85,610 sharesChange vs previous 13F +6,899 shares
<0.01% of the 13F portfolio, value $7,005,466.
13F-HR/A 0000312069-26-000080 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F/A 78,711 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $5,296,464.
13F-HR/A 0000312069-26-000089 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).